Open Access

Anticoagulation management in non-valvular atrial fibrillation: optimising patient outcomes

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Oral Anticoagulation
Session type: Industry Q&A session
Sponsored by Bristol Myers Squibb and Pfizer
Date: 30 August 2020
Time: 12:45 - 13:45

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

4 presentations in this session

Anticoagulation in non-valvular atrial fibrillation: Current landscape.

Speaker: Professor S. Hohnloser (Frankfurt, DE)
Thumbnail

Improving outcomes for non-valvular atrial fibrillation patients with acute coronary syndrome and/or requiring percutaneous coronary intervention.

Speaker: Professor R. Lopes (Durham, US)
Thumbnail

Improving patient outcomes through atrial fibrillation screening: Current situation and future directions.

Speaker: Doctor E. Svennberg (Stockholm, SE)
Thumbnail

Questions and Answers: Are we closing knowledge and practice gaps?

Speaker: Professor S. Hohnloser (Frankfurt, DE)
Speaker: Professor R. Lopes (Durham, US)
Speaker: Doctor E. Svennberg (Stockholm, SE)
Thumbnail

6 speakers from this session

Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)
27 presentations
1 follower

Professor Renato Lopes

Duke University Medical Center, Duke Clinical Research Institute, Durham (United States of America)
20 presentations
0 follower

Doctor Emma Svennberg

Karolinska Institute, Stockholm (Sweden)
16 presentations
4 followers

Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)
27 presentations
1 follower

Professor Renato Lopes

Duke University Medical Center, Duke Clinical Research Institute, Durham (United States of America)
20 presentations
0 follower

Doctor Emma Svennberg

Karolinska Institute, Stockholm (Sweden)
16 presentations
4 followers

This platform is supported by

logo Novo Nordisk